- Aditx Therapeutics (NASDAQ:ADTX) said on Friday that it intends to execute a 1-for-40 reverse stock split to regain compliance with the Nasdaq’s minimum bid price requirement.
- The company’s common stock will trade on a post-split basis under the same symbol ADTX on October
